ArticleHarm reduction journal2020
Providing reproductive health services for women who inject drugs: a pilot program.
Article in Harm reduction journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 28 citations in OpenAlex.
- Sexually transmitted infection prevalence and testing coverage among people who inject drugs: A systematic review.Drug and alcohol dependence · 2025Pooled it
- The HIV pre-exposure prophylaxis continuum of care among women who inject drugs: A systematic review.Frontiers in psychiatry · 2022Pooled it
- A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial.Addiction (Abingdon, England) · 2023Trial
- Exploring Sexually Transmitted and Bloodborne Infection Rates in Florida After Implementation of Syringe Services Programs: A Quasi-Experimental Study.AJPM focus · 2026Article
- Contraceptive and condom use among women from key populations in Myanmar.Harm reduction journal · 2026Article
- Cervical Cancer Screening With Human Papillomavirus Self-Collection Testing in an Opioid Treatment Program.JAMA network open · 2026Article
- Drug use and sexual behaviors among women who inject drugs and use a syringe services program; Miami, Florida.Harm reduction journal · 2025Article
- An exploratory study on the use of sexually transmitted infection prevention and contraception methods among women and men who use unprescribed opioids.Drug and alcohol dependence reports · 2025Article
- Harm Reduction as a Form of 'Wrap-Around' Care: The Nursing Role.International journal of mental health nursing · 2025Review
- Understanding the needs of postpartum emerging adults with substance use disorders to improve recovery supports.Frontiers in public health · 2025Article
- Examining the association between psychological resilience and chronic versus discrete stressors among individuals who use opioids in Baltimore, Maryland.Drug and alcohol review · 2025Article
- Reaching people who use drugs with sexual and reproductive healthcare through syringe services programs: potential promise and missed opportunities.Harm reduction journal · 2024Article
- Facilitators and barriers to monitoring and evaluation at syringe service programs.Harm reduction journal · 2024Article
- Opportunities for cancer prevention at syringe services programs: acceptability of HPV self-sampling and vaccination among people who inject drugs.Harm reduction journal · 2024Article
- Evaluation of self-directed specimen collection for chlamydia and gonorrhea testing among people who use drugs.International journal of STD & AIDS · 2024Article
- Programs and practices that support pregnant people who use drugs' access to sexual and reproductive health care in Canada: a scoping review.BMC pregnancy and childbirth · 2024Article
- Trauma-Informed Approaches in the Context of Cancer Care in Canada and the United States: A Scoping Review.Trauma, violence & abuse · 2023Article
- Cervical cancer screening, abnormal results, and follow-up in women with substance use-related diagnoses.Substance abuse · 2022Article
- Miscarriage and Abortion Among Women Attending Harm Reduction Services in Philadelphia: Correlations With Individual, Interpersonal, and Structural Factors.Substance use & misuse · 2022Article
- Long-acting reversible contraceptives (LARCs) as harm reduction: a qualitative study exploring views of women with histories of opioid misuse.Harm reduction journal · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeedle syringe programs (NSPs), a proven harm reduction strategy for people who inject drugs, frequently offer limited healthcare services for their clients. Women who inject drugs face multiple barriers to accessing reproductive health care in traditional settings: personal histories of trauma, judgmental treatment from providers, and competing demands on their time. Our aim was to implement patient-centered reproductive healthcare services at a Seattle NSP.
methodsWe interviewed clients and staff of an NSP in Seattle and staff of other community-based organizations serving women who inject drugs, then used the Consolidated Framework for Implementation Research to code transcripts deductively. Based on our qualitative work, we implemented reproductive health care at the NSP program 1 day per week. We evaluated the implementation by surveying staff and clients and auditing charts over a 9-month period.
resultsClients and staff (N = 15 for clients, N = 13 for staff) noted a high unmet need for trauma-informed, accessible reproductive health care. We successfully implemented reproductive health care services including short- and long-acting contraception, sexually transmitted disease testing, and cervical cancer screening. Survey data was limited but demonstrated client satisfaction with services.
conclusionsIntegrating reproductive health care into an NSP's clinical services is feasible and can be a source of low-barrier preventive care for women unable to seek gynecologic care elsewhere.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.